Crossref journal-article
Wiley
Immunological Reviews (311)
Abstract

Summary: Human NK cells express several specialized inhibitory receptors that recognize major histocompatibility complex (MHC) class I molecules expressed on normal cells. The lack of expression of one or more HLA CLASS I alleles leads to NK‐mediated target cell lysis. Receptors specific for groups of HLA‐C (p58), HLA‐B (p70) and HLA‐A (p140) alleles belong to the Ig superfamily with two or three Ig‐like domains in their extracellular portion, and a long cytoplasmic tail containing ITIM motifs and associated with a non‐polar transmembrane portion. In contrast, the CD94/NKG2‐A receptor complex is composed of type II proteins with a C‐type lectin domain which displays a more broad specificity for different class I alleles. Recently, activatory forms of the HLA‐C‐specific receptors have been identified in some donors. They are virtually identical to the inhibitory forms in their extracellular portions, but display a short cytoplasmic tail lacking ITIM motifs associated with a Lys‐containing transmembrane portion (p50). A subset of activated T‐lymphocytes. primarily CD8+ and oligoclonal or monoclonal in nature, express NK‐type class I‐specific receptors. These receptors exert an inhibitory activity on T‐cell receptor‐mediated functions and may provide an important mechanism of down‐regulation of T‐cell responses.

Bibliography

Moretta, A., Biassoni, R., Bottino, C., Pende, D., Vitale, M., Poggi, A., Mingari, M. C., & Moretta, L. (1997). Major histocompatibility complex class I‐specific receptors on human natural killer and T lymphocytes. Immunological Reviews, 155(1), 105–117. Portico.

Authors 8
  1. Alessandro Moretta (first)
  2. Roberto Biassoni (additional)
  3. Cristina Bottino (additional)
  4. Daniela Pende (additional)
  5. Massimo Vitale (additional)
  6. Alessandro Poggi (additional)
  7. Maria Cristina Mingari (additional)
  8. Lorenzo Moretta (additional)
References 92 Referenced 279
  1. 10.1002/ijc.2910160204
  2. 10.1002/eji.1830050208
  3. 10.1016/S0065-2776(08)60664-1
  4. 10.1002/eji.1830061209
  5. {'key': 'e_1_2_1_6_2', 'first-page': '1566', 'volume-title': 'NK cells and other natural effector cells', 'author': 'Herberman RB.', 'year': '1982'} / NK cells and other natural effector cells by Herberman RB. (1982)
  6. 10.1007/978-1-4613-0715-0
  7. 10.1016/0952-7915(93)90030-V
  8. 10.1016/S0065-2776(08)60513-1
  9. 10.1146/annurev.immunol.14.1.619
  10. 10.1016/0167-5699(90)90097-S
  11. 10.1016/0960-9822(92)90179-E
  12. 10.1016/0167-5699(92)90042-6
  13. 10.1084/jem.162.6.1745
  14. 10.4049/jimmunol.135.6.4281 / J Immunol / YAC‐1 MHC class I variants reveal an association between decreased NK sensitivity and increased H‐2 expression after interferon treatment or in vivo passage by Piontek GE (1985)
  15. 10.4049/jimmunol.138.6.1657 / J Immunol / NK susceptibility varies inversely with target cell class I HLA antigen by Storkus WJ (1987)
  16. 10.4049/jimmunol.138.4.1297 / J Immunol / Phenotypic and functional characterization of recombinant interleukin‐2 (rIL‐2)‐induced activated killer cells. Analysis at the population and clonal levels by Ferrini S. (1987)
  17. {'key': 'e_1_2_1_18_2', 'first-page': '6', 'article-title': 'Novel surface molecules involved in human NK cell activation triggering of the lytic machinery', 'volume': '7', 'author': 'Moretta A', 'year': '1992', 'journal-title': 'Int J Cancer suppl.'} / Int J Cancer suppl. / Novel surface molecules involved in human NK cell activation triggering of the lytic machinery by Moretta A (1992)
  18. 10.1002/ijc.2910440429
  19. 10.4049/jimmunol.136.11.3939 / J Immunol / Induction and blocking of cytolysis in CD2+, CD3‐ NK and CD2+, CD3+ cytotoxic T lymphocytes via CD2 50 kD sheep erythrocyte receptor by Bolhuis RL (1986)
  20. 10.1084/jem.174.6.1393
  21. {'key': 'e_1_2_1_22_2', 'first-page': '1', 'article-title': 'MHC molecules in normal and neoplastic cells', 'volume': '6', 'author': 'Garrido F.', 'year': '1996', 'journal-title': 'Int J Cancer'} / Int J Cancer / MHC molecules in normal and neoplastic cells by Garrido F. (1996)
  22. 10.1073/pnas.84.5.1356
  23. 10.1084/jem.176.3.729
  24. 10.1016/S0065-230X(08)60713-7
  25. 10.1084/jem.175.3.843
  26. 10.1038/349329a0
  27. 10.1084/jem.175.3.709
  28. 10.1084/jem.172.1.47
  29. 10.1084/jem.176.4.963
  30. 10.1084/jem.178.2.597
  31. 10.1073/pnas.90.24.12000
  32. 10.1084/jem.182.2.605
  33. 10.1002/eji.1830240434
  34. 10.1093/intimm/7.3.393
  35. 10.1084/jem.178.4.1321
  36. 10.1084/jem.171.3.695
  37. 10.1084/jem.172.6.1589
  38. 10.1006/smim.1995.0010
  39. 10.1159/000319335
  40. 10.1016/1074-7613(95)90025-X
  41. 10.1126/science.7716543
  42. 10.1084/jem.181.6.1953
  43. 10.1016/S1074-7613(00)80300-3
  44. 10.4049/jimmunol.156.12.4531 / J Immunol / Human and mouse natural killer cell inhibitory receptors recruit the PTP1C and PTP1D protein tyrosine phosphatases by Olcese L. (1996)
  45. 10.1084/jem.184.1.93
  46. 10.1126/science.7716523
  47. 10.1126/science.7618087
  48. 10.1182/blood.V85.1.87.bloodjournal85187
  49. {'key': 'e_1_2_1_50_2', 'article-title': 'Mouse mast cell gp49B1 contains two immunoreceptor tyrosine‐based inhibition motifs and suppresses mast cell activation when coligated with the high‐affinity Fc receptor for IgE', 'author': 'Katz HR', 'journal-title': 'Proc Natl Acad Sci USA'} / Proc Natl Acad Sci USA / Mouse mast cell gp49B1 contains two immunoreceptor tyrosine‐based inhibition motifs and suppresses mast cell activation when coligated with the high‐affinity Fc receptor for IgE by Katz HR
  50. 10.1016/1074-7613(95)90069-1
  51. 10.1084/jem.182.3.875
  52. 10.1084/jem.183.2.645
  53. 10.1002/eji.1830260823
  54. 10.1084/jem.180.2.537
  55. 10.1073/pnas.93.4.1453
  56. 10.1084/jem.181.3.1133
  57. 10.1126/science.7863326
  58. 10.4049/jimmunol.155.5.2306
  59. 10.1084/jem.184.2.505
  60. 10.4049/jimmunol.156.9.3098 / J Immunol / A human killer inhibitory receptor specific for HLA‐A by Döhring C (1996)
  61. 10.1146/annurev.iy.11.040193.003145
  62. 10.1084/jem.180.2.545
  63. 10.1006/smim.1995.0011
  64. 10.1002/eji.1830261032
  65. 10.4049/jimmunol.144.8.3238 / J Immunol / A novel functional cell surface dimer (Kp43) expressed by natural killer cells and T cell receptor‐γ/δ+ T lymphocytes. Inhibition of IL‐2 dependent proliferation by anti‐Kp43 monoclonal antibody by Aramburu J (1990)
  66. 10.4049/jimmunol.154.11.5779 / J Immunol / Functional ambivalence of the Kp43 (CD94) NK cell‐associated surface antigen by PereAz‐Villar JJ (1995)
  67. 10.4049/jimmunol.157.12.5367 / J Immunol / Biochemical and serological evidence for the existence of functionally distinct isoforms of the CD94 NK‐cell receptor by Pérez‐ Villar JJ (1996)
  68. 10.1002/eji.1830250904
  69. {'key': 'e_1_2_1_70_2', 'article-title': 'The CD94 and NKG2‐A C‐type lectins covalently assemble to form a NK cell inhibitory receptor for HLA class I molecules', 'author': 'Carretero M', 'journal-title': 'Eur J Immunol'} / Eur J Immunol / The CD94 and NKG2‐A C‐type lectins covalently assemble to form a NK cell inhibitory receptor for HLA class I molecules by Carretero M
  70. 10.1084/jem.173.4.1017
  71. 10.4049/jimmunol.157.11.4741 / J Immunol / Human natural killer cell receptors involved in MHC class I recognition are disulphide‐linked hecerodimers of CD94 and NKG2 subunits by Lazetic S (1996)
  72. 10.1016/0092-8674(95)90466-2
  73. 10.1016/S1074-7613(94)80020-0
  74. 10.1073/pnas.92.8.3536
  75. 10.1002/eji.1830250523
  76. 10.1073/pnas.88.22.10332
  77. 10.1126/science.1853205
  78. 10.1073/pnas.91.14.6520
  79. 10.1084/jem.179.2.661
  80. 10.1002/eji.1830241005
  81. 10.1093/intimm/7.4.697
  82. 10.1126/science.7716542
  83. {'key': 'e_1_2_1_84_2', 'article-title': 'Human CD8+ T lymphocyte subsets that express HLA‐class I specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations', 'author': 'Mingari MC', 'journal-title': 'Proc Natl Acad Sci USA'} / Proc Natl Acad Sci USA / Human CD8+ T lymphocyte subsets that express HLA‐class I specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations by Mingari MC
  84. {'key': 'e_1_2_1_85_2', 'first-page': '135', 'article-title': 'HLA‐class I‐specific inhibitory receptors of NK type on a subset of T cells', 'volume': '64', 'author': 'Mingari MC', 'journal-title': 'Chem I mmunol'} / Chem I mmunol / HLA‐class I‐specific inhibitory receptors of NK type on a subset of T cells by Mingari MC
  85. 10.4049/jimmunol.151.10.5762 / J Immunol / Clonal predominanc e of T cell receptors within the CD8‐CD45RO+ subset in normal human subjects by Hingorani R. (1993)
  86. 10.1146/annurev.iy.11.040193.000405 / Ann Rev Immunol / Immunological memory by Gray D. (1993)
  87. {'key': 'e_1_2_1_88_2', 'article-title': 'HLA‐class I‐specific inhibitory receptors in human cytolytic T lymphocytes. Molecular characterization, distribution in lymphoid tissues and coexpression by individual T cells', 'author': 'Mingari MC', 'journal-title': 'Immunol'} / Immunol / HLA‐class I‐specific inhibitory receptors in human cytolytic T lymphocytes. Molecular characterization, distribution in lymphoid tissues and coexpression by individual T cells by Mingari MC
  88. 10.1038/370463a0
  89. 10.4049/jimmunol.155.10.5046 / J Immunol / CD8highCD57+ T lymphocytes in normal, healthy individuals are oligoclonal and respond to human cytomegalovirus by Whang EC (1995)
  90. 10.1128/jvi.70.2.843-851.1996 / J Virology / Analysis of the T‐cell receptor repertoire of human T‐cell leukemia virus type‐1 (HTLV‐1). Tax‐specific CD8+ cytotoxic T lymphocytes from patients with HTLV‐1‐associated disease: evidence for oligoclonal expansion by Utz U (1996)
  91. 10.4049/jimmunol.154.7.3538 / J Immunol / Analysis of clonal CD8+ T cell expansions in normal individuals and patients with rheumatoid arhtiritis by Fitzgerald JE (1995)
  92. 10.1006/clin.1994.1029
Dates
Type When
Created 19 years, 3 months ago (April 29, 2006, 7:50 p.m.)
Deposited 1 year, 10 months ago (Oct. 27, 2023, 11:25 a.m.)
Indexed 2 months, 3 weeks ago (June 6, 2025, 9:05 a.m.)
Issued 28 years, 6 months ago (Feb. 1, 1997)
Published 28 years, 6 months ago (Feb. 1, 1997)
Published Online 19 years, 4 months ago (April 28, 2006)
Published Print 28 years, 6 months ago (Feb. 1, 1997)
Funders 0

None

@article{Moretta_1997, title={Major histocompatibility complex class I‐specific receptors on human natural killer and T lymphocytes}, volume={155}, ISSN={1600-065X}, url={http://dx.doi.org/10.1111/j.1600-065x.1997.tb00943.x}, DOI={10.1111/j.1600-065x.1997.tb00943.x}, number={1}, journal={Immunological Reviews}, publisher={Wiley}, author={Moretta, Alessandro and Biassoni, Roberto and Bottino, Cristina and Pende, Daniela and Vitale, Massimo and Poggi, Alessandro and Mingari, Maria Cristina and Moretta, Lorenzo}, year={1997}, month=feb, pages={105–117} }